March 1, 2016 8:19am

Appoints Peter J. Mariani as CFO, Greg Freitag continues as General Counsel and Senior VP of Business Development


 

AXGN appointed Peter J. Mariani, as Chief Financial Officer, effective March 1, 2016. Mr. Mariani will report directly to Karen Zaderej, President and CEO. Greg Freitag, who has been the interim CFO since August 2015, will continue as General Counsel, Senior VP of Business Development and a member of the Board of Directors.

 

Prior to joining AxoGen, Mr. Mariani was the Chief Financial Officer of Lensar, Inc., a privately-held global leader in next generation femtosecond laser technology for refractive cataract surgery. Prior to Lensar he served as Chief Financial Officer at Hansen Medical, Inc., a publicly-traded company that designs and manufactures medical robotics for positioning and control of catheter-based technologies. Mr. Mariani was also with Guidant Corporation, a global leader in the development and sale of medical devices for the treatment of cardiovascular disease. During his 12 years at Guidant, he held senior financial positions of increasing importance, including Vice President of Finance and Administration, Guidant Japan, and the corporate Vice President, Controller and Chief Accounting Officer. Following the sale of Guidant to Boston Scientific in 2006, Mr. Mariani co-led the global integration of the companies. He started his career at Ernst and Young, LLP, where he served a diverse client base as a CPA.